EMEA-002581-PIP01-19

Table of contents

Key facts

Active substance
Emixustat (hydrochloride)
Therapeutic area
Ophthalmology
Decision number
P/0369/2020
PIP number
EMEA-002581-PIP01-19
Pharmaceutical form(s)
  • Age-appropriate oral solid dosage form
  • Tablet
Condition(s) / indication(s)
Treatment of Stargardt disease
Route(s) of administration
Oral use
Contact for public enquiries
Kubota Pharmaceutical Holdings Co. Limited

E-mail: ClinicalTrials@acucela.com
Tel. +1 2068058310

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating